Blog Archives

Swissmedic schliesst Überprüfung der Antibabypillen ab

22. Oktober 2009 –  Das Schweizerische Heilmittelinstitut (Swissmedic) hat heute die untenstehende  Mitteilung herausgegen. Sie betrifft Drospirenon-haltige Antibabypillen, welche in der Schweiz als Angeliq®, Yasmin®, Yasminelle®, und YAZ® auf dem Markt sind.

Antibabypillen,

Read more ›

Tags: , , , , , ,

Drospirenon-haltige Kontrazeptiva: Risiko von Venenthrombosen und Lungenembolien mit den Produkten Yasmin, Yasminelle, und Yaz.

25. März 2010 – Einer heutigen Mitteilung können wir entnehmen, dass das Schweizerische Heilmittelinstitut (Swissmedic) das Überprüfungsverfahren der Drospirenon-haltigen Kontrazeptiva abgeschlossen hat.

Die Fach- und Patienteninformation der kombinierten oralen Kontrazeptiva (“Antibaby-Pillen”) Yasmin®, Yasminelle®, und Yaz®,

Read more ›

Tags: , , , , , , , , , ,

Venöse Thromboembolien unter Antibabypillen : Swissmedic informiert über Abklärungen und erinnert an die Vorsichtsmassnahmen

28. Juli 2011 – Das Schweizerische Heilmittelinstitut (Swissmedic) hat heute folgendermassen informiert (Text im Wortlaut folgend):

_________________

Antibabypillen, die den Wirkstoff Drospirenon enthalten, sind im Risikobereich der anderen auf dem Markt erhältlichen Präparate. Das Risiko für Frauen, eine venöse Thromboembolie zu bekommen, ist wie bei allen Antibabypillen im ersten Jahr der Einnahme am stärksten erhöht.

Read more ›

Tags: , , , , , , ,

Deutschland: Drospirenon-haltige orale Kontrazeptiva (z.B. Yasmin®) – Aktualisierung der Produkt-Informationen zum Risiko venöser Thromboembolien

24. September 2011 – Ähnlich wie Swissmedic in der Schweiz (siehe untenstehende Blog-Post) hat kürzlich das BfArM in Deutschland zu den Risiken venöser thromboembolischer Ereignisse (VTE) bei der Anwendung drospirenonhaltiger kombinierter oraler Kontrazeptiva informiert. Frauen können nicht genügend auf dieses zwar seltene, jedoch real existierende Risiko (mit möglichem fatalen Ausgang) der medikamentösen Schwangerschaftsverhütung hingewiesen werden.

Read more ›

Tags: , , , , ,

thasso: zustände

thasso: neueste tweets

thasso: kürzliche kommentare

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • Single-cell RNA sequencing reveals details about individual cells in pancreatic tumors September 30, 2020
    Led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and by HonorHealth Research and Innovation Institute, an international team of researchers have described in detail the individual cells that comprise the pancreatic cancer microenvironment, a critical step in devising new treatment options for patients with this aggressive and difficult-to-treat disease.
  • Study: Neanderthal genes are a liability for COVID patients September 30, 2020
    Scientists say genes that some people have inherited from their Neanderthal ancestors may increase their likelihood of suffering severe forms of COVID-19.
  • Concealed cardiomyopathies revealed in cardiac arrest survivors September 30, 2020
    Centenary Institute researchers have discovered that genetic testing can identify "concealed cardiomyopathies" in nearly a quarter of sudden cardiac arrest (SCA) survivors who seem to have a normal heart.
  • Genetic risk of developing obesity is driven by variants that affect the brain September 29, 2020
    Some people are at higher risk of developing obesity because they possess genetic variants that affect how the brain processes sensory information and regulates feeding and behavior. The findings from scientists at the University of Copenhagen support a growing body of evidence that obesity is a disease whose roots are in the brain.
  • Inflammatory gene provides clue to obesity risk September 29, 2020
    A gene that helps to control inflammation increases the risk of obesity and could be turned off in mice to stop weight gain, a study from The University of Queensland has found.
  • Single-cell RNA sequencing reveals details about individual cells in pancreatic tumors September 30, 2020
    Led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and by HonorHealth Research and Innovation Institute, an international team of researchers have described in detail the individual cells that comprise the pancreatic cancer microenvironment, a critical step in devising new treatment options for patients with this aggressive and difficult-to-treat disease. […]
  • Ocean warming and acidification effects on calcareous phytoplankton communities September 30, 2020
    A new study led by researchers from the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona (ICTA-UAB) warns that the negative effects of rapid ocean warming on planktonic communities will be exacerbated by ocean acidification.
  • Videos most effective in communicating with parents about secondhand smoke risks September 30, 2020
    The best way to communicate with parent smokers about the risks of secondhand smoke to their children is to use videos depicting the risks, as well as solutions to reduce those risks.
  • Antipsychotics for treating adult depression linked with higher mortality September 30, 2020
    Rutgers researchers, together with colleagues at Columbia University, have reported an increased mortality risk in adults with depression who initiated augmentation with newer antipsychotic medications compared to a control group that initiated augmentation with a second antidepressant.
  • Is it time to reframe the assisted dying debate? September 30, 2020
    Several articles published by The BMJ today explore the debate around assisted dying, in which, subject to safeguards, terminally ill people who are near to death, suffering, and of sound mind, could ask for drugs that they would take to end their lives.
Top